232 related articles for article (PubMed ID: 33107433)
1. MECHANISMS IN ENDOCRINOLOGY: Update on treatments for patients with genetic obesity.
Poitou C; Mosbah H; Clément K
Eur J Endocrinol; 2020 Nov; 183(5):R149-R166. PubMed ID: 33107433
[TBL] [Abstract][Full Text] [Related]
2. Rare genetic causes of obesity: Diagnosis and management in clinical care.
Dubern B; Mosbah H; Pigeyre M; Clément K; Poitou C
Ann Endocrinol (Paris); 2022 Feb; 83(1):63-72. PubMed ID: 34953778
[TBL] [Abstract][Full Text] [Related]
3. Current Treatments for Patients with Genetic Obesity.
Faccioli N; Poitou C; Clément K; Dubern B
J Clin Res Pediatr Endocrinol; 2023 May; 15(2):108-119. PubMed ID: 37191347
[TBL] [Abstract][Full Text] [Related]
4. Rare genetic forms of obesity in childhood and adolescence: A narrative review of the main treatment options with a focus on innovative pharmacological therapies.
Mainieri F; La Bella S; Rinaldi M; Chiarelli F
Eur J Pediatr; 2024 Apr; 183(4):1499-1508. PubMed ID: 38227053
[TBL] [Abstract][Full Text] [Related]
5. Rare genetic forms of obesity: From gene to therapy.
Clément K; Mosbah H; Poitou C
Physiol Behav; 2020 Dec; 227():113134. PubMed ID: 32805220
[TBL] [Abstract][Full Text] [Related]
6. [Monogenic and syndromic symptoms of morbid obesity. Rare but important].
Wiegand S; Krude H
Internist (Berl); 2015 Feb; 56(2):111-2, 114-20. PubMed ID: 25630806
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials.
Clément K; van den Akker E; Argente J; Bahm A; Chung WK; Connors H; De Waele K; Farooqi IS; Gonneau-Lejeune J; Gordon G; Kohlsdorf K; Poitou C; Puder L; Swain J; Stewart M; Yuan G; Wabitsch M; Kühnen P;
Lancet Diabetes Endocrinol; 2020 Dec; 8(12):960-970. PubMed ID: 33137293
[TBL] [Abstract][Full Text] [Related]
8. Rare Genetic Forms of Obesity: Clinical Approach and Current Treatments in 2016.
Huvenne H; Dubern B; Clément K; Poitou C
Obes Facts; 2016; 9(3):158-73. PubMed ID: 27241181
[TBL] [Abstract][Full Text] [Related]
9. Bariatric Surgery for Monogenic Non-syndromic and Syndromic Obesity Disorders.
Vos N; Oussaada SM; Cooiman MI; Kleinendorst L; Ter Horst KW; Hazebroek EJ; Romijn JA; Serlie MJ; Mannens MMAM; van Haelst MM
Curr Diab Rep; 2020 Jul; 20(9):44. PubMed ID: 32729070
[TBL] [Abstract][Full Text] [Related]
10. Genetic obesity: an update with emerging therapeutic approaches.
Sohn YB
Ann Pediatr Endocrinol Metab; 2022 Sep; 27(3):169-175. PubMed ID: 36203267
[TBL] [Abstract][Full Text] [Related]
11. Mendelian obesity, molecular pathways and pharmacological therapies: a review.
Paolacci S; Borrelli A; Stuppia L; Campanile FC; Dallavilla T; Krajčovič J; Veselenyiova D; Beccari T; Unfer V; Bertelli M;
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1357-1378. PubMed ID: 30779104
[TBL] [Abstract][Full Text] [Related]
12. Update on treatment strategies for obesity.
Wyatt HR
J Clin Endocrinol Metab; 2013 Apr; 98(4):1299-306. PubMed ID: 23443815
[TBL] [Abstract][Full Text] [Related]
13. Insights into the Allosteric Mechanism of Setmelanotide (RM-493) as a Potent and First-in-Class Melanocortin-4 Receptor (MC4R) Agonist To Treat Rare Genetic Disorders of Obesity through an in Silico Approach.
Falls BA; Zhang Y
ACS Chem Neurosci; 2019 Mar; 10(3):1055-1065. PubMed ID: 30048591
[TBL] [Abstract][Full Text] [Related]
14. Leptin Receptor Compound Heterozygosity in Humans and Animal Models.
Berger C; Klöting N
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922961
[TBL] [Abstract][Full Text] [Related]
15. An overview of the management of morbid obesity.
Monkhouse SJ; Morgan JD; Bates SE; Norton SA
Postgrad Med J; 2009 Dec; 85(1010):678-81. PubMed ID: 20075407
[TBL] [Abstract][Full Text] [Related]
16. Psychopathological Behaviour and Cognition in Morbid Obesity.
Calderone A; Calabro PF; Lippi C; Jaccheri R; Vitti J; Santini F
Recent Pat Endocr Metab Immune Drug Discov; 2017; 10(2):112-118. PubMed ID: 28029083
[TBL] [Abstract][Full Text] [Related]
17. Update on endocrine aspects of childhood obesity.
Baskaran C; Kandemir N
Curr Opin Endocrinol Diabetes Obes; 2018 Feb; 25(1):55-60. PubMed ID: 29135487
[TBL] [Abstract][Full Text] [Related]
18. Differentiating monogenic and syndromic obesities from polygenic obesity: Assessment, diagnosis, and management.
Fitch AK; Malhotra S; Conroy R
Obes Pillars; 2024 Sep; 11():100110. PubMed ID: 38766314
[TBL] [Abstract][Full Text] [Related]
19. Setmelanotide (Imcivree) for rare genetic forms of obesity.
Med Lett Drugs Ther; 2021 Jul; 63(1629):e3-e4. PubMed ID: 34544109
[No Abstract] [Full Text] [Related]
20. Approaches to obesity management.
Sweeting AN; Caterson ID
Intern Med J; 2017 Jul; 47(7):734-739. PubMed ID: 28677316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
